Astec LifeSciences Limited has informed the Exchange regarding Appointment of Mr Burjis Nadir Godrej as Managing Director of the Company w.e.f. April 01, 2025.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 3.0 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shareholders of Astec LifeSciences have approved the appointment of Mr. Burjis Nadir Godrej as Managing Director via postal ballot on May 30, 2025. His term is for 5 years, effective from April 1, 2025 to March 31, 2030. Notably, he will serve without any remuneration in this role. The company confirmed he is not barred from holding a director's position by SEBI or any other authority. Astec LifeSciences is part of the Godrej group, and Mr. Burjis Nadir Godrej appears to be a member of the promoter family.
For shareholders, this signals stronger promoter family involvement in managing the company, which may bring strategic continuity but also concentrates decision-making within the family. The fact that he is not taking any remuneration is a positive signal of long-term commitment.